Successful treatment of MRSA empyema in children: A case report

Diah Ayu Pitaloka () and Retno Asih Setyoningrum ()

Edelweiss Applied Science and Technology, 2025, vol. 9, issue 2, 567-574

Abstract: The increasing prevalence of Methicillin-Resistant Staphylococcus aureus (MRSA) infection globally is largely attributed to community-acquired strains. Among pediatric patients, community-acquired MRSA has emerged as a significant cause of severe complications, including pneumonia with pleural effusion, empyema, necrotizing pneumonia, and abscess formation. Although staphylococcal pneumonia was previously uncommon in children, it is now associated with notable morbidity and mortality. This case report presents a 6-year-old and 11-month-old boy diagnosed with MRSA empyema. His treatment involved targeted antibiotic therapy guided by sputum culture results, pleural fluid drainage, and nutritional support. Given the limited available literature, this report highlights the diagnostic and therapeutic challenges in managing such cases and emphasizes the need for additional research to establish standardized treatment guidelines.

Keywords: Children; Community-acquired pneumonia; Empyema; MRSA; Pneumonia. (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://learning-gate.com/index.php/2576-8484/article/view/4522/1738 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ajp:edwast:v:9:y:2025:i:2:p:567-574:id:4522

Access Statistics for this article

More articles in Edelweiss Applied Science and Technology from Learning Gate
Bibliographic data for series maintained by Melissa Fernandes ().